Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer
Clinical trial NCT02789878 · COMPLETED
Trial details
- NCT number
- NCT02789878
- Sponsor
- Instituto do Cancer do Estado de São Paulo
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2022-04-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.